• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎患者中组织型纤溶酶原激活剂(t-PA)及其特异性抑制剂(PAI-1)的失衡与疾病活动度相关。

Imbalance of tissue-type plasminogen activator (t-PA) and its specific inhibitor (PAI-1) in patients with rheumatoid arthritis associated with disease activity.

作者信息

Kopeikina L T, Kamper E F, Koutsoukos V, Bassiakos Y, Stavridis I

机构信息

Department of Experimental Physiology, Medical School, University of Athens, Greece.

出版信息

Clin Rheumatol. 1997 May;16(3):254-60. doi: 10.1007/BF02238960.

DOI:10.1007/BF02238960
PMID:9184262
Abstract

The relationship between plasma fibrinogen, D-dimer (DD), t-PA and PAI-1 and their correlation with disease activity (DA) were studied in 45 patients with rheumatoid arthritis (RA) (group B) to further understand the implication of fibrinolysis in the pathophysiology of RA. The control group constituted 24 healthy subjects (group A). A Stoke index (SI) of DA was assigned to each patient. Patients were divided into two groups: C, minimal-mild DA (SI 1-7); D, moderate-severe DA (SI 8-17). Fibrinogen was elevated in RA correlating positively with SI and CRP. Hypercoagulability counteracted by reactive fibrinolysis was inferred from a 10-fold increase of DD in group B as compared to group A. The relatively lower levels of DD in group D compared to group C and their negative correlation with SI (r(s) = -0.49, p = 0.0006) indicate the tendency of fibrinolysis to decrease with the increase of DA. Significant elevation of t-PA and PAI-1 were found in group B compared to group A. While t-PA progressively decreased with the increase of DA (r(s) = -0.45, p = 0.0019), a positive relation of PAI-1 to DA was observed (r = 0.42, p = 0.0042). A 2-fold increase of PAI-1/t-PA molar ratio in group D compared to groups A and C as well as its positive correlation with SI (r(s) = 0.63, p = 0.0001) indicate the displacement of balance between t-PA and PAI-1 in favour of the inhibitor with the increase of DA in RA. The involvement of inflammatory mediators in PAI-1/t-PA imbalance was proposed from the relation of fibrinolytic abnormalities with the activity of systemic inflammatory process.

摘要

对45例类风湿关节炎(RA)患者(B组)的血浆纤维蛋白原、D - 二聚体(DD)、组织型纤溶酶原激活物(t - PA)和纤溶酶原激活物抑制剂 - 1(PAI - 1)之间的关系及其与疾病活动度(DA)的相关性进行了研究,以进一步了解纤溶在RA病理生理学中的意义。对照组为24名健康受试者(A组)。为每位患者指定了DA的卒中指数(SI)。患者分为两组:C组,轻度 - 中度DA(SI 1 - 7);D组,重度 - 重度DA(SI 8 - 17)。RA患者的纤维蛋白原升高,与SI和CRP呈正相关。从B组与A组相比DD增加10倍推断,反应性纤溶抵消了高凝状态。与C组相比,D组中DD水平相对较低,且与SI呈负相关(r(s)= - 0.49,p = 0.0006),这表明纤溶有随DA增加而降低的趋势。与A组相比,B组中t - PA和PAI - 1显著升高。虽然t - PA随DA增加而逐渐降低(r(s)= - 0.45,p = 0.0019),但观察到PAI - 1与DA呈正相关(r = 0.42,p = 0.0042)。与A组和C组相比,D组中PAI - 1/t - PA摩尔比增加2倍,且与SI呈正相关(r(s)= 0.63,p = 0.0001),这表明在RA中随着DA增加,t - PA和PAI - 1之间的平衡向有利于抑制剂的方向偏移。从纤溶异常与全身炎症过程活动的关系中提出了炎症介质参与PAI - 1/t - PA失衡的观点。

相似文献

1
Imbalance of tissue-type plasminogen activator (t-PA) and its specific inhibitor (PAI-1) in patients with rheumatoid arthritis associated with disease activity.类风湿关节炎患者中组织型纤溶酶原激活剂(t-PA)及其特异性抑制剂(PAI-1)的失衡与疾病活动度相关。
Clin Rheumatol. 1997 May;16(3):254-60. doi: 10.1007/BF02238960.
2
The effect of disease activity related cytokines on the fibrinolytic potential and cICAM-1 expression in rheumatoid arthritis.疾病活动相关细胞因子对类风湿关节炎纤溶潜力及细胞间黏附分子-1表达的影响
J Rheumatol. 2000 Nov;27(11):2545-50.
3
Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis.类风湿关节炎患者的血浆纤连蛋白水平与疾病活动度
J Rheumatol. 1997 Feb;24(2):262-8.
4
Alterations in the fibrinolytic system components during acute myocardial infarction.急性心肌梗死期间纤溶系统成分的改变。
Acta Cardiol. 2000 Aug;55(4):247-53. doi: 10.2143/AC.55.4.2005747.
5
Fibrinolytic activity in peripheral atherosclerosis in the elderly.老年人外周动脉粥样硬化中的纤溶活性。
Thromb Haemost. 1999 Feb;81(2):275-80.
6
Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics.1型纤溶酶原激活物抑制剂对缺血性心脏病患者组织型纤溶酶原激活物介导的纤维蛋白溶解的调节作用:利尿剂可能产生的不利影响。
Coron Artery Dis. 1994 Jul;5(7):617-23. doi: 10.1097/00019501-199407000-00010.
7
The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria.2型糖尿病正常白蛋白尿和微量白蛋白尿患者中凝血酶激活的纤溶抑制物(TAFI)、组织型纤溶酶原激活物(t-PA)、纤溶酶原激活物抑制剂-1(PAI-1)与纤维蛋白肽A和Bβ1-42(F1 + 2)之间的关系。
Blood Coagul Fibrinolysis. 2011 Sep;22(6):493-8. doi: 10.1097/MBC.0b013e328346f8ca.
8
The effects of TNF alpha inhibition on plasma fibrinolytic balance in patients with chronic inflammatory rheumatical disorders.肿瘤坏死因子α抑制对慢性炎症性风湿性疾病患者血浆纤溶平衡的影响。
Clin Exp Rheumatol. 2006 Sep-Oct;24(5):580-3.
9
[Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].[闭塞性动脉粥样硬化症和糖尿病大血管病变患者的纤溶酶原激活剂(组织型纤溶酶原激活剂和尿激酶型纤溶酶原激活剂)及其他纤溶参数]
Pol Merkur Lekarski. 2001 Nov;11(65):414-7.
10
Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.女性的身体活动状况以及凝血和纤溶因子中与年龄相关的不利差异
Arterioscler Thromb Vasc Biol. 1998 Mar;18(3):362-8. doi: 10.1161/01.atv.18.3.362.

引用本文的文献

1
Accelerated Spatial Fibrin Growth and Impaired Contraction of Blood Clots in Patients with Rheumatoid Arthritis.类风湿关节炎患者的血液凝块加速空间纤维蛋白生长和收缩受损。
Int J Mol Sci. 2020 Dec 11;21(24):9434. doi: 10.3390/ijms21249434.
2
The relationship between periodontal status and rheumatoid arthritis - systematic review.牙周状况与类风湿性关节炎的关系——系统评价
Reumatologia. 2020;58(4):236-242. doi: 10.5114/reum.2020.98436. Epub 2020 Aug 31.
3
Interrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockade.

本文引用的文献

1
[Rapid physiological coagulation method in determination of fibrinogen].[快速生理凝血法测定纤维蛋白原]
Acta Haematol. 1957 Apr;17(4):237-46. doi: 10.1159/000205234.
2
Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis.类风湿关节炎患者的血浆纤连蛋白水平与疾病活动度
J Rheumatol. 1997 Feb;24(2):262-8.
3
Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis.类风湿关节炎中的组织型纤溶酶原激活剂、纤溶酶原激活剂抑制剂-1和血管性血友病因子
白细胞介素-6受体阻断后类风湿关节炎患者血清中趋化素和纤溶酶原激活物抑制剂-1水平的相关降低
Clin Rheumatol. 2015 Mar;34(3):419-27. doi: 10.1007/s10067-014-2704-1. Epub 2014 Jun 10.
4
Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors.类风湿关节炎的止血功能紊乱:与人口统计学、炎症和代谢因素的关联。
Clin Rheumatol. 2013 Sep;32(9):1357-64. doi: 10.1007/s10067-013-2283-6. Epub 2013 May 15.
5
Fibrinolysis is down-regulated in mouse collagen-induced arthritis, but its normalization does not alleviate the course of disease.纤维蛋白溶解在胶原诱导的关节炎小鼠中受到抑制,但这种抑制的正常化并不能减轻疾病的进程。
Inflamm Res. 2011 Nov;60(11):1021-9. doi: 10.1007/s00011-011-0363-0. Epub 2011 Jul 24.
Clin Rheumatol. 1993 Sep;12(3):318-24. doi: 10.1007/BF02231572.
4
Physiological consequences of loss of plasminogen activator gene function in mice.小鼠纤溶酶原激活物基因功能缺失的生理后果。
Nature. 1994 Mar 31;368(6470):419-24. doi: 10.1038/368419a0.
5
Increase of activated factor VIIA and haemostatic molecular markers in juvenile chronic arthritis.青少年慢性关节炎中活化凝血因子VIIA及止血分子标志物的增加
Br J Rheumatol. 1995 May;34(5):466-9. doi: 10.1093/rheumatology/34.5.466.
6
Correlation between clotting and collagen metabolism markers in rheumatoid arthritis.类风湿关节炎中凝血与胶原代谢标志物之间的相关性
Thromb Haemost. 1994 Feb;71(2):199-202.
7
The fibrinolytic system and its relation to inflammatory diseases.纤维蛋白溶解系统及其与炎症性疾病的关系。
Semin Arthritis Rheum. 1982 May;11(4):390-8. doi: 10.1016/0049-0172(82)90026-9.
8
Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA.基于三种抗人组织型纤溶酶原激活剂(t-PA)的鼠单克隆抗体,采用酶联免疫吸附测定(ELISA)法检测人组织型纤溶酶原激活剂(t-PA)。
Thromb Haemost. 1985 Oct 30;54(3):684-7.
9
Dynamic coronary fibrinolysis evaluation in patients with myocardial infarction and unstable angina by specific plasma fibrin degradation product determination.通过特定血浆纤维蛋白降解产物测定对心肌梗死和不稳定型心绞痛患者进行动态冠状动脉纤溶评估。
Thromb Res. 1987 Feb 15;45(4):383-92. doi: 10.1016/0049-3848(87)90227-1.
10
The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozolol.增加类风湿关节炎患者纤维蛋白溶解作用的效果:司坦唑醇的双盲研究
Q J Med. 1986 Jan;58(225):19-27.